MARSHALL WACE, LLP – Xenon Pharmaceuticals Inc. Transaction History
MARSHALL WACE, LLP portfolio value:
$101.48M
portfolio value
MARSHALL WACE, LLP quarter portfolio value change:
+18.67%
quarter
Xenon Pharmaceuticals Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +41.23% | 820.72K shares | 40.93M | $36.1 | 2.81M |
| Q2 2022 | share | Increase | +29.75% | 456.31K shares | 13.65M | $30.42 | 1.99M |
| Q1 2022 | share | Increase | +25.64% | 313.10K shares | 8.75M | $30.57 | 1.53M |
| Q4 2021 | share | Increase | +3996.76% | 1.19M shares | 37.68M | $31.99 | 1.22M |
| Q3 2021 | share | Increase | +185.11% | 19.35K shares | 261K | $15.28 | 29.80K |
| Q2 2021 | share | Increase | 0.00% | 10.45K shares | 195K | $18.62 | 10.45K |
| Q4 2020 | share | Decrease | -100.00% | -37.34K shares | -413K | $15.38 | 0 |
| Q3 2020 | share | Decrease | -54.96% | -45.56K shares | -627K | $11.07 | 37.34K |
| Q2 2020 | share | Increase | 0.00% | 82.91K shares | 1.04M | $12.54 | 82.91K |
| Q1 2020 | share | Decrease | -100.00% | -48.60K shares | -637K | $11.34 | 0 |
| Q4 2019 | share | Increase | 0.00% | 48.60K shares | 637K | $13.11 | 48.60K |